Confronta i metodi

	Valutazione Funzionale della Terapia Oncologica-Mammella (FACT-B)	Scala di Valutazione dei Sintomi Memoriale (MSAS)
Campo	Infermieristica oncologica	Infermieristica oncologica
Famiglia	Process / pipeline	Process / pipeline
Anno di origine	1997	1994
Ideatore	Marilyn Brady and David Cella	Russell Portenoy
Tipo	Patient self-report disease-specific QoL instrument	Patient self-report multisymptom prevalence and distress scale
Fonte seminale	Brady, M. J., Cella, D. F., Mo, F., et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15(3), 974–986.	Portenoy, R. K., Thaler, H. T., Kornblith, A. B., et al. (1994). The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer, 30A(9), 1326–1336.
Alias	FACT-B, FACT-Breast	MSAS, MSAS-SF
Correlati	4	4
Sintesi	The FACT-B is a comprehensive 36-item disease-specific quality-of-life instrument that integrates the generic FACT-G (27 items covering physical, social, emotional, and functional well-being) with a 9-item breast-cancer-specific subscale addressing body image, sexual function, arm symptoms, and treatment side effects. Developed by Brady et al. in 1997, the FACT-B is the gold-standard QoL measure for breast cancer research and clinical practice, used in hundreds of clinical trials and enabling comparison across breast cancer populations and treatment modalities.	The Memorial Symptom Assessment Scale is a comprehensive multisymptom instrument that captures both prevalence and distress of 32 cancer-related symptoms (full version) or 10 core symptoms (short form). Developed by Portenoy and colleagues at Memorial Sloan Kettering Cancer Center in 1994, the MSAS is designed for detailed symptom profiling in oncology research and clinical practice, enabling identification of symptom clusters and assessment of physical and psychological symptom burden separately.